Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma
NCT02860936Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jun 2015
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenvatinib in adenoid cystic carcinoma (ACC), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Jun 2015; status: completed.
02
Drugs
lenvatinib
03
Conditions
adenoid cystic carcinoma (ACC)
Beyond the preview
Go deeper on NCT02860936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02860936.